Qianmai Bomile

Shanghai Qianmai Bomile Medical Laboratory is a Sino-foreign joint venture "medical laboratory" established by Shanghai New Hongqiao International Medical Center, which introduced an internationally renowned brand to provide testing services and pathological diagnosis services to medical institutions with more advanced testing technology and refined quality management. The foreign partner of the laboratory, BML Co., Ltd., is a leading Japanese "clinical testing" professional brand with nearly 60 years of industry experience and is listed on the Tokyo Stock Exchange. In terms of laboratory testing technology, operational automation, and quality system construction*, among which: BML has established a comprehensive testing system covering over 4,000 clinical testing items, ranging from routine biochemical and immunological tests to genetic, molecular pathological, and other examinations. It is particularly outstanding in the field of microbiological testing, achieving automation in microbiology testing and improving the limitations of visual identification of bacterial species. Challenging the world's unique laboratory automation, Frontier system, developed and used by BML for pre-analytical processing, combines barcode systems, automatic transportation systems, and automatic sample separation systems, and introduces robotic transportation systems to freely transport testing samples based on analyzer information; the Symphony fully automated biochemical analysis management system and fully automated blood analysis management system have significantly improved testing capabilities. Moreover, a high degree of automation ensures safe, high-speed, and accurate testing results, avoiding error rates caused by human factors. These equipment are first created by BML and are unique. Comprehensive quality system: Quality management is one of BML's core values. Through a comprehensive quality system and processes, it ensures the precision and accuracy of testing data. The industry quality systems that BML has passed include CAP accreditation, ISO15189 accreditation, ISO9001 accreditation, ISO13485 accreditation, ISO17025 accreditation, ISO27001 accreditation, as well as ServiceMark accreditation and PrivacyMark accreditation. It has also passed the environmental system accreditation ISO14001. Committed to the development and research of the latest testing technologies: BML has developed testing technologies in fields such as genetic diseases, allergies, and infectious diseases, as well as in genetic gene analysis, including single nucleotide polymorphism, genetic gene analysis, genetic gene expression analysis, and infectious gene expression analysis, and applies them clinically. Meanwhile, through personnel training and technology transfer, it serves medical institutions at all levels with internationally cutting-edge testing technology. Committed to the field of medical diagnosis and providing excellent services for human health, this is the mission that Qianmai Bomile has given itself and the direction of continuous efforts.